| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | alendronic acid (Binosto®) |
| Formulation | 70 mg effervescent tablet |
| Reference number | 2966 |
| Indication | Treatment of postmenopausal osteoporosis |
| Company | Internis Pharmaceuticals Ltd |
| BNF chapter | Endocrine system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 30/11/2015 |